BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.97B
AUM Growth
-$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$12.1M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$12M
5
CRL icon
Charles River Laboratories
CRL
+$6.28M

Top Sells

1
+$91.2M
2
+$42.4M
3
+$26.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.3M
5
AXSM icon
Axsome Therapeutics
AXSM
+$14.3M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0.59%
3 Energy 0.02%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$40.9M 0.59%
166,355
-3,154
52
$40.8M 0.59%
3,571,870
-63,016
53
$38.6M 0.55%
647,163
-9,518
54
$38.5M 0.55%
161,164
+6,049
55
$36.8M 0.53%
930,500
-40,800
56
$36.7M 0.53%
1,129,653
+371,630
57
$36.6M 0.53%
72,144
+326
58
$36.1M 0.52%
414,284
-11,539
59
$36M 0.52%
189,774
-2,814
60
$35.5M 0.51%
108,822
-6,951
61
$33.6M 0.48%
767,300
-68,384
62
$31.6M 0.45%
5,439,551
-521,678
63
$29.1M 0.42%
657,188
-44,880
64
$29M 0.42%
160,227
-8,371
65
$28.3M 0.41%
4,225,264
-10,000
66
$27.7M 0.4%
265,270
-817
67
$27.6M 0.4%
163,304
+7,496
68
$27.3M 0.39%
653,814
+73,927
69
$27.2M 0.39%
571,721
-900
70
$26.1M 0.37%
303,100
-400
71
$26M 0.37%
157,591
-11,185
72
$25.5M 0.37%
625,461
-4,978
73
$25.3M 0.36%
7,325,514
74
$25.1M 0.36%
642,447
+551
75
$24.6M 0.35%
941,871
+812
1 2
3
4 5